NAV
$42.84
AUM
$2.5B
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.94
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +10.23% | +1.54% | +6.11% | +21.48% | +18.01% | +13.59% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 2.97% |
| 2 | HSBA.L | HSBC Holdings PLC | 1.45% |
| 3 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.32% |
| 4 | NESN.SW | Nestle SA | 1.32% |
| 5 | AZN.L | AstraZeneca PLC | 1.27% |
| 6 | SIE.DE | Siemens AG | 1.15% |
| 7 | BHP.AX | BHP Group Ltd | 1.13% |
| 8 | NOVN.SW | Novartis AG Registered Shares | 1.11% |
| 9 | 7203.T | Toyota Motor Corp | 1.04% |
| 10 | BNP.PA | BNP Paribas Act. Cat.A | 1.03% |
The fund invests at least 80% of its assets in the component securities of the index and in depositary receipts representing such securities. The index is based on the Morningstar® Developed Markets ex-North America Target Market Exposure Index and is constructed by applying an optimization process to the Parent Index that aims to deliver a higher dividend yield than the Parent Index, while limiting expected tracking error to the Parent Index.
Inception Date: 2016-06-01